首页 | 本学科首页   官方微博 | 高级检索  
     


Tumorigenicity of CHO glycosylation mutants in the nude mouse
Authors:P Stanley
Affiliation:1. Institute for Chemical and Bioengineering, Department of Chemistry and Applied Biosciences, ETH Zurich, 8093 Zurich, Switzerland;2. Department of Chemical Engineering, University of Chemistry and Technology, Technicka 5, 166 28 Prague, Czech Republic;1. Pharma Technical Development, Roche Diagnostics GmbH, Sandhofer Str. 116, 68305 Mannheim, Germany;2. Pharma Technical Development, Roche Diagnostics GmbH, Nonnenwald 2, 82377 Penzberg, Germany;3. Pharma Technical Development, Genentech, South San Francisco, CA 94080, USA;4. Pharma Technical Development Biotech Europe, F. Hoffmann-La Roche Ltd, 4070 Basel, Switzerland;1. Laboratory of Gene Therapy, Department of Veterinary and Biosciences, Faculty of Veterinary Medicine, Ghent University, Heidestraat 19, B-9820 Merelbeke, Belgium;2. SINTEF Industry, Dept. of Biotechnology and Nanomedicine, Research Group Mass Spectrometry, Sem Sælands v. 2A, N-7034 Trondheim, Norway;3. Laboratory of Gene Therapy, Department of Veterinary and Biosciences, Faculty of Veterinary Medicine, Ghent University, Heidestraat 19, B-9820 Merelbeke, Belgium;4. SINTEF Industry, Dept. of Biotechnology and Nanomedicine, Research Group Mass Spectrometry, Sem Sælands v. 2A, N-7034 Trondheim, Norway;1. Evonik Operations GmbH, Goldschmidtstr. 100, D-45127 Essen, Germany;2. The Dow Chemical Company, 1803 Building, Midland, MI, 48674, USA;3. The Procter & Gamble Company, Mason Business Center | 8700 Mason Montgomery Rd. | Mason, Ohio, 45040, USA
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号